Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Crispr/Cas13: A Potential Therapeutic Option of Covid-19 Publisher Pubmed



Lotfi M1, 2, 3 ; Rezaei N2, 4, 5
Authors
Show Affiliations
Authors Affiliations
  1. 1. School of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran
  2. 2. Network of Immunity in Infection, Malignancy and Autoimmunity (NIIMA), Universal Scientific Education and Research Network (USERN), Tehran, Iran
  3. 3. USERN Office, Zanjan University of Medical Sciences, Zanjan, Iran
  4. 4. Research Center for Immunodeficiencies, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran
  5. 5. Department of Immunology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran

Source: Biomedicine and Pharmacotherapy Published:2020


Abstract

The novel coronavirus called severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can be considered as the most important current global issue, as it has caused the novel coronavirus disease (COVID-19) pandemic, which has resulted in high mortality and morbidity rates all around the world. Although scientists are trying to discover novel therapies and develop and evaluate various previous treatments, at the time of writing this paper, there was no definite therapy and vaccine for COVID-19. So, as COVID-19 has called ideas for treatment, controlling, and diagnosis, we discussed the application of Clustered Regularly Interspaced Short Palindromic Repeats/Cas13 (CRISPR/Cas13) as a treatment of COVID-19, which received less attention compared with other potential therapeutic options. © 2020
Related Docs
View other Related Docs
1. Sars-Cov-2: A Comprehensive Review From Pathogenicity of the Virus to Clinical Consequences, Journal of Medical Virology (2020)
2. Casilico: A Versatile Crispr Package for in Silico Crispr Rna Designing for Cas12, Cas13, and Cas14, Frontiers in Bioengineering and Biotechnology (2022)
3. Covid-19: Transmission, Prevention, and Potential Therapeutic Opportunities, Clinica Chimica Acta (2020)
4. The Trend of Crispr-Based Technologies in Covid-19 Disease: Beyond Genome Editing, Molecular Biotechnology (2023)
5. The Significance of Bioengineered Nanoplatforms Against Sars-Cov-2: From Detection to Genome Editing, Life Sciences (2021)
6. Precision Medicine in Infectious Disease, Precision Medicine in Clinical Practice (2022)
7. Immunopathological Similarities Between Covid-19 and Influenza: Investigating the Consequences of Co-Infection, Microbial Pathogenesis (2021)
8. Variants in Ace2; Potential Influences on Virus Infection and Covid-19 Severity, Infection# Genetics and Evolution (2021)
Experts (# of related papers)
View all Related Experts
Nima Rezaei (34)
Mohammadreza Salehi (5)
Other Related Docs
9. Point-Of-Use Rapid Detection of Sars-Cov-2: Nanotechnology-Enabled Solutions for the Covid-19 Pandemic, International Journal of Molecular Sciences (2020)
10. Host Factors: Implications in Immunopathogenesis of Covid-19, Pathology Research and Practice (2021)
11. Sars-Cov-2: From the Pathogenesis to Potential Anti-Viral Treatments, Biomedicine and Pharmacotherapy (2021)
12. Pharmacological Treatments of Covid-19, Pharmacological Reports (2020)
13. Covid-19: Our Current Knowledge of Epidemiology, Pathology, Therapeutic Approaches, and Diagnostic Methods, Anti-Cancer Agents in Medicinal Chemistry (2021)
14. Cancer Care Management During the Covid-19 Pandemic, Risk Management and Healthcare Policy (2020)
15. Protection of Animals Against Devastating Rna Viruses Using Crispr-Cas13s, Molecular Therapy Nucleic Acids (2024)
16. Computer-Assisted Multi-Epitopes T-Cell Subunit Covid-19 Vaccine Design, Biomedical and Biotechnology Research Journal (2021)
17. Crispr-Based Gene Editing in Plants: Focus on Reagents and Their Delivery Tools, BioImpacts (2025)
18. Prevalence of Sars-Cov-2 Infection in Neonates Born to Mothers or Relatives With Covid-19, BMC Infectious Diseases (2022)
19. Targeted Therapy Strategies Against Sars-Cov-2 Cell Entry Mechanisms: A Systematic Review of in Vitro and in Vivo Studies, Journal of Cellular Physiology (2021)
20. Nanotheranostics Against Covid-19: From Multivalent to Immune-Targeted Materials, Journal of Controlled Release (2020)
21. Targeted Delivery of Crispr/Cas13 As a Promising Therapeutic Approach to Treat Sars-Cov-2, Current Pharmaceutical Biotechnology (2021)
22. A Review on Currently Available Potential Therapeutic Options for Covid-19, International Journal of General Medicine (2020)
23. Sars-Cov-2: Current Trends in Emerging Variants, Pathogenesis, Immune Responses, Potential Therapeutic, and Vaccine Development Strategies, International Immunopharmacology (2021)
24. Geriatrics and Covid-19, Advances in Experimental Medicine and Biology (2021)
25. Severe Acute Respiratory Syndrome-Coronavirus-2 Spike (S) Protein Based Vaccine Candidates: State of the Art and Future Prospects, Reviews in Medical Virology (2021)
26. Computed Tomography Scan in Covid-19: A Systematic Review and Meta-Analysis, Polish Journal of Radiology (2022)
27. Human Coronaviruses Sars-Cov, Mers-Cov, and Sars-Cov-2 in Children, Journal of Pediatric Nursing (2021)
28. Auxiliary Role of Mesenchymal Stem Cells As Regenerative Medicine Soldiers to Attenuate Inflammatory Processes of Severe Acute Respiratory Infections Caused by Covid-19, Cell and Tissue Banking (2020)
29. Evolutionary Study of Covid-19, Severe Acute Respiratory Syndrome Coronavirus 2 (Sars-Cov-2) As an Emerging Coronavirus: Phylogenetic Analysis and Literature Review, Veterinary Medicine and Science (2021)
30. An Overview on the Seven Pathogenic Human Coronaviruses, Reviews in Medical Virology (2022)
31. The Role of Type I Interferon in the Treatment of Covid-19, Journal of Medical Virology (2022)
32. The Roles of the Kynurenine Pathway in Covid-19 Neuropathogenesis, Infection (2024)
33. Risk Factors for Adverse Outcomes of Covid-19 Patients: Possible Basis for Diverse Responses to the Novel Coronavirus Sars-Cov-2, Life Sciences (2021)
34. The Chimera of S1 and N Proteins of Sars-Cov-2: Can It Be a Potential Vaccine Candidate for Covid-19?, Expert Review of Vaccines (2022)
35. Targeting the Vital Non-Structural Proteins (Nsp12, Nsp7, Nsp8 and Nsp3) From Sars-Cov-2 and Inhibition of Rna Polymerase by Natural Bioactive Compound Naringenin As a Promising Drug Candidate Against Covid-19, Journal of Molecular Structure (2023)
36. The Clinical Value of Two Combination Regimens in the Management of Patients Suffering From Covid-19 Pneumonia: A Single Centered, Retrospective, Observational Study, DARU# Journal of Pharmaceutical Sciences (2020)
37. The Situation of Small Molecules Targeting Key Proteins in Combatting Sars-Cov-2: Synthesis, Metabolic Pathway, Mechanism of Action, and Potential Therapeutic Applications, Mini-Reviews in Medicinal Chemistry (2022)
38. Design of an Engineered Ace2 As a Novel Therapeutics Against Covid-19, Journal of Theoretical Biology (2020)
39. Nanostructures for Prevention, Diagnosis, and Treatment of Viral Respiratory Infections: From Influenza Virus to Sars-Cov-2 Variants, Journal of Nanobiotechnology (2023)
40. Nanoparticles-Mediated Crispr/Cas9 Delivery: Recent Advances in Cancer Treatment, Journal of Drug Delivery Science and Technology (2020)
41. Sars-Cov-2; What We Know so Far, Archives of Iranian Medicine (2020)
42. The Immune System As a Target for Therapy of Sars-Cov-2: A Systematic Review of the Current Immunotherapies for Covid-19, Life Sciences (2020)
43. Biomarker Based Biosensors: An Opportunity for Diagnosis of Covid-19, Reviews in Medical Virology (2022)
44. Modern Diagnostics Processes Among New Strains of Coronaviruses: A Review, Journal of Datta Meghe Institute of Medical Sciences University (2022)
45. Antiviral Optical Techniques As a Possible Novel Approach to Covid-19 Treatment, Journal of Innovative Optical Health Sciences (2021)
46. Immune Responses and Pathogenesis of Sars-Cov-2 During an Outbreak in Iran: Comparison With Sars and Mers, Reviews in Medical Virology (2020)
47. Green Chemistry and Coronavirus, Sustainable Chemistry and Pharmacy (2021)
48. Sars-Cov-2 in Brief: From Virus to Prevention, Osong Public Health and Research Perspectives (2022)
49. Vlp-Based Covid-19 Vaccines: An Adaptable Technology Against the Threat of New Variants, Vaccines (2021)
50. Evidence for Sars-Cov-2 Circulating Among Stray Dogs and Cats: Should We Worry About Our Pets During the Covid-19 Pandemic?, Biomedical and Biotechnology Research Journal (2020)